Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28047710 | 0.98 | EPHX2 (0.32) | EPHX2TET2RECQLTSHR | |
| SCHEMBL4591586 | 0.94 | CA12 (0.32) | — | |
| SCHEMBL1888270 | 0.85 | GAA (0.38) | EPHX2 | |
| SCHEMBL607551 | 0.80 | — | — | |
| SCHEMBL10798431 | 0.80 | — | — | |
| SCHEMBL27817578 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL5031179 | 0.79 | — | — | |
| SCHEMBL10529046 | 0.79 | KDM1A (0.36) | — | |
| SCHEMBL27791582 | 0.79 | — | — | |
| SCHEMBL28043248 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118834859-A | For synthesizing cefradine penicillin G acylase of (A) | 上海邦林生物科技有限公司 | 2024-10-25 | — | — | CN | claimed |
| CN-113387824-A | High-purity D-dihydro phenyl glycine methyl ester and preparation method thereof | 华北制药股份有限公司 | 2021-09-14 | — | — | CN | claimed |
| EP-1641933-B1 | PROCESS FOR THE PREPARATION OF CEPHRADINE | DSM SINOCHEM PHARM NL BV (NL) | 2017-12-20 | — | — | EP | claimed |
| EP-1931619-B1 | METHANESULPHONIC ACID SALT OF DIHYDROPHENYLGLYCINE METHYL ESTER OR OF PHENYLGLYCINE METHYL ESTER | DSM SINOCHEM PHARM NL BV (NL) | 2015-06-24 | — | — | EP | claimed |
| US-20110104748-A1 | PROCESS FOR THE PREPARATION OF BETA-LACTAM COMPOUNDS | DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) | 2011-05-05 | — | — | US | claimed |
| EP-2121960-A1 | PROCESS FOR THE PREPARATION OF BETA-LACTAM COMPOUNDS | DSM IP Assets B.V. (NL) | 2009-11-25 | — | — | EP | claimed |
| WO-2008110527-A1 | PROCESS FOR THE PREPARATION OF BETA-LACTAM COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2008-09-18 | — | — | WO | claimed |
| CN-118834859-A | For synthesizing cefradine penicillin G acylase of (A) | 上海邦林生物科技有限公司 | 2024-10-25 | — | — | CN | disclosed |
| CN-109971743-B | Penicillin G acylase mutant derived from achromobacter CCM4824 and application thereof | 艾美科健株式会社 | 2022-09-06 | — | — | CN | disclosed |
| CN-113387824-A | High-purity D-dihydro phenyl glycine methyl ester and preparation method thereof | 华北制药股份有限公司 | 2021-09-14 | — | — | CN | disclosed |
| CN-109971743-A | From the penicillin G acylase mutant of achromobacter CCM4824 and its application | 艾美科健株式会社 | 2019-07-05 | — | — | CN | disclosed |
| CN-109971742-A | From the penicillin G acylase mutant of achromobacter CCM 4824 and its application | 艾美科健株式会社 | 2019-07-05 | — | — | CN | disclosed |
| US-20180222848-A1 | Salt of Dihydrophenylglycine Methyl Ester | DSM SINOCHEM PHARM NL BV (NL) | 2018-08-09 | — | — | US | disclosed |
| WO-2008110527-A1 | PROCESS FOR THE PREPARATION OF BETA-LACTAM COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2008-09-18 | — | — | WO | disclosed |
| WO-2008110529-A1 | PROCESS FOR THE PREPARATION OF AMINO ACID METHYL ESTERS | DSM IP ASSETS B.V. (NL) | 2008-09-18 | — | — | WO | disclosed |
| EP-1931619-A2 | PROCESS FOR ESTERIFICATION OF AN ORGANIC ACID | DSMIP Assets B.V. (NL) | 2008-06-18 | — | — | EP | disclosed |
| WO-2007039522-A2 | PROCESS FOR ESTERIFICATION OF AN ORGANIC ACID | DSM IP ASSETS B.V. (NL) | 2007-04-12 | — | — | WO | disclosed |
| US-20060189802-A1 | Process for the preparation of cephradine | DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL) | 2006-08-24 | — | — | US | disclosed |
| EP-1641933-A2 | PROCESS FOR THE PREPARATION OF CEPHRADINE | DSM IP Assets B.V. (NL) | 2006-04-05 | — | — | EP | disclosed |
| WO-2005003367-A2 | PROCESS FOR THE PREPARATION OF CEPHRADINE | DSM IP ASSETS B.V. (NL) | 2005-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180222848-A1 | Salt of Dihydrophenylglycine Methyl Ester | DNPEP, DDC, DHPS | EPHX2 1897/4885TET2 113/4885RECQL 4283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.